MoneyWorks4Me

Cadila Healthcare reports Profit after tax of Rs 141.00 Mln, in the September 2021 quarter

29 Oct 2021 Evaluate
The revenue declined to Rs. 20089.00 millions for the quarter ended September 2021 as compared to Rs. 20569.00 millions during the corresponding quarter last year.Net profit was down at Rs. 141.00  millions against Rs. 4730.00 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -97.02%.The company reported a degrowth in operating Profit to 5537.00 millions from 6884.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 20089.00 20569.00 -2.33 41323.00 38528.00 7.25 77904.00 63474.00 22.73
Other Income 694.00 608.00 14.14 991.00 808.00 22.65 789.00 8494.00 -90.71
PBIDT 5537.00 6884.00 -19.57 12010.00 12976.00 -7.44 23980.00 22725.00 5.52
Interest 241.00 149.00 61.74 683.00 348.00 96.26 709.00 2339.00 -69.69
PBDT 2103.00 6735.00 -68.78 8134.00 12628.00 -35.59 21396.00 19866.00 7.70
Depreciation 1192.00 1121.00 6.33 2359.00 2230.00 5.78 4511.00 4289.00 5.18
PBT 911.00 5614.00 -83.77 5775.00 10398.00 -44.46 16885.00 15577.00 8.40
TAX 770.00 884.00 -12.90 1635.00 1686.00 -3.02 2123.00 2041.00 4.02
Deferred Tax 43.00 -111.00 -138.74 58.00 -150.00 -138.67 -910.00 400.00 -327.50
PAT 141.00 4730.00 -97.02 4140.00 8712.00 -52.48 14762.00 13536.00 9.06
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 27.56 33.47 -17.65 29.06 33.68 -13.70 30.78 35.80 -14.02
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..